In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which dramatically changed his patient's quality of life. 

Send us a text

In this episode, Dr. Cohen sits down with Sarah Nielsen, Genetic Counselor to talk about her experience educating and developing screening protocols for providers who are new to the genetics space. The implications of genetic mutations,family history and the limitations of access to genetic counselors are also discussed and how collaborative  solutions are being employed to move this important testing forward in the Urology space. 

Send us a text

In this episode, Dr. Cohen sits down with Dr. Mark Edney, Medical Director at Peninsula Institute for Laparoscopic and Robotic Surgery to discuss the limitations of relying on clinical pathology alone and how the addition of Prolaris allows providers to truly understand how a patient's tumor is behaving on a biological level. Dr, Edney also talks about his personal use of biomarkers in his practice and why he believes there is a slow adoption rate of molecular tests in the Urology space. Familial cancer screening and use of hereditary cancer testing to further personalize prostate cancer treatment is also discussed 

Send us a text

Dr. Todd Cohen, Medical Director of Urology at Myriad Genetics discusses his intentions for creating this casual, yet educational podcast about modern topics in Urology.

Enjoy! 

Send us a text